It was reported that there was a problem with a progav 2.0 shuntsytsem.This product was implanted in (b)(6) 2020.In (b)(6) 2020, the patient was admitted to the hospital for reexamination.During the operation, the doctor found that there was no fluid flowing out of the abdominal cavity.It was difficult to press the fluid reservoir and the shunt tube was blocked.The shunt tube has been removed from the patient.No further patient datas are available at this time.
|
- updated information in b5 and section d - investigation result: visual inspection: the following observations were made during the visual inspection: -some particles in the delivery liquid, but no defects or other abnormalities are detected permeability test: the test showed that the progav 2.0 shunt system is non-permeable.To determine the location of the occlusion, the shunt system was dismantled and each element was tested individually for permeability.The test showed that the progav 2.0 and the shuntassistant is permeable, while the distal peritoneal catheter is non-permeable.We could see a coloration of the catheter.During flushing the catheter, a yellowish substance flushed out, which might be the cause of the blockage.Adjustability test: the progav 2.0 was found to be adjustable to all pressure settings.The shuntassistant is a fixed pressure valve, therefore the adjustability test is inapplicable.Braking force and brake function test: the braking force of the progav 2.0 was within the specified tolerance and the brake function operated as expected.Internal inspection of product: in order to verify whether the investigated shunt system was compromised by the known risks of hydrocephalus therapy, e.G.By a build-up of natural substances (protein, blood, or tissue particles) in the cerebrospinal fluid, we have dismantled the valves.After dismantling of the valves, no deposits were found in both valves.Results: based on our investigation, we are able to substantiate the claim of "blockage".We are assuming that the deposits detected within the catheter have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
|